Publications by authors named "F Piscaglia"

Claim this Profile
L
Lenvatinib sorafenib as second-line treatment post atezolizumab plus bevacizumab for hepatocellular carcinoma: The LEVIATHAN study.
Pasquale Lombardi, Jung Sun Kim, Giulia F Manfredi, Ciro Celsa, Claudia A M Fulgenzi, Fabio Piscaglia

JHEP Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Yin-Yang of HCC management: Reconciling therapeutic hierarchy and transplant benefit in real-world evidence.
Alessandro Vitale, Fabio Piscaglia, Angelo Sangiovanni, Giuseppe Cabibbo, Francesco Paolo Russo

Liver Transpl· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary biliary cholangitis (PBC): evolving approaches and expert perspectives.
Pietro Invernizzi, Aghemo Alessio Michele Goffredo, Vincenza Calvaruso, Ana Lleo, Marco Marzioni, Fabio Piscaglia

Expert Rev Gastroenterol Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic profiling in hepatocellular carcinoma: a real-world retrospective analysis.
F Salani, F R Ponziani, F Piscaglia, U Malapelle, B Daniele

ESMO Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of a Bundle for the Management of Patients With Gram-Negative Bloodstream Infection: A Pre-Post Quasi-experimental Study.
Cecilia Bonazzetti, Andrea Grechi, Dino Gibertoni, Ludovica Mangione, Fulvia Todisco, Fabio Piscaglia

Open Forum Infect Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis